News

Displaying 1 - 10 of 13

Horizon 2020 funding for UK participants - if there’s no Brexit deal in October 2019

Tomorrow will see a new Prime Minister take on the BREXIT challenge. Specifically, he has not ruled out a no deal scenario. Delivering the deal negotiated with the EU remains the government’s top priority. This has not changed. The text below is the governments current advice to UK participants. It deals with funding issues.

Are you a European or registered to vote in an EU country? Upcoming European Elections in May

The European elections for the European Parliament are being held in May 2019. This is your chance to have a directtly elected representative at the top table when discussing thenext Science and research budget for the next R&D programme starting in 2021 and going 7 years forward.

After Horizon 2020, the new R&D budget proposes a modest increase to 100B Euro

up from 80 Billion for the period 2014-2020. So this is about a 3%-4% annual increase only proposed, which is marginally higher than the rate fo inflation for most years in some of tghe EU countries.

Many scientists think this is less than ambitious; though the EU has other issues to deal with - such as the potential loss of the UK contribution.

UK Participation in H2020 in the forthcoming Transition period- Green Light (in theory) to end 2020

Having asked the Commission formally what the situation of UK entities is during the transition period from March 30th 2018 to 31 Dec 2020, after 6 weeks of posing and posting the question to various parts of DG Research (responsible for the whole H2020 Programe and Budget), the managing Research Executive Agency and Europe Direct, I had not obtained a single concrete answer to the questio

Confidentiality and Non-Disclosure Agreements - Models in multiple languages for H2020 consortia and individual use

Confidentiality is an extremely important issue for participants in R&D projects, from the setting-up (even during earliest discussions on the assessment of participation), to the implementation and exploitation phases.

A scientific perspective on the regulatory status of products derived from gene editing

The European Commission’s Scientific Advice Mechanism (SAM) Group of Chief Scientific Advisors has on18 November 2018, published a statement providing ‘a scientific perspective on the regulatory status of products derived from gene editing, and the implications for the GMO Directive’.